Membrane-targeting approaches for enhanced cancer cell destruction with irreversible electroporation

Annals of Biomedical Engineering

Volumn 42, Issue 1, 2014, Pages 193-204

  Jiang, Chunlan ^a   Qin, Zhenpeng ^a   Bischof, John ^a,b  

^a University of Minnesota   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Adjuvant; Cancer treatment; DMSO; Irreversible electroporation; Membrane permeabilization; Pulse timing

Indexed keywords

ADJUVANT; DMSO; ELECTROPORATION; MEMBRANE PERMEABILIZATION; PULSE TIMING;

DISEASES; ONCOLOGY;

MEMBRANES;

CYTOTOXIC AGENT; DIMETHYL SULFOXIDE; SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL DESTRUCTION; CELL MEMBRANE; CELL STRAIN LNCAP; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; ELECTROPORATION; HUMAN; HUMAN CELL; IRREVERSIBLE ELECTROPORATION; MALE; MEMBRANE PERMEABILITY; MEMBRANE TARGETING; MOUSE; NONHUMAN; PULSE TIMING; PULSED ELECTRIC FIELD; SKINFOLD; SURFACE TENSION; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR SEEDING; TUMOR VOLUME;

CELL LINE, TUMOR; CELL MEMBRANE; CRYOPROTECTIVE AGENTS; DIMETHYL SULFOXIDE; ELECTROCHEMOTHERAPY; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 84896697555     PISSN: 00906964     EISSN: 15739686     Source Type: Journal    
DOI: 10.1007/s10439-013-0882-7     Document Type: Article

References (46)

1. Al-Sakere, B., F. André, C. Bernat, E. Connault, P. Opolon, R. V. Davalos, B. Rubinsky, and L. M. Mir. Tumor ablation with irreversible electroporation. PLoS ONE 2(11):e1135, 2007.
2. Au, J. T., T. P. Kingham, K. Jun, D. Haddad, S. Gholami, K. Mojica, S. Monette, P. Ezell, and Y. Fong. Irreversible electroporation ablation of the liver can be detected with ultrasound B-mode and elastography. Surgery 153(6):787-793, 2013.
3. Bao, N., T. T. Le, J.-X. Cheng, and C. Lu. Microfluidic electroporation of tumor and blood cells: observation of nucleus expansion and implications on selective analysis and purging of circulating tumor cells. Integr. Biol. (Camb.) 2(2-3):113-120, 2010.
4. Cheng, D. K. L., L. Tung, and E. A. Sobie. Nonuniform responses of transmembrane potential during electric field stimulation of single cardiac cells. Am. J. Physiol. Heart Circ. Physiol. 277(1):H351-H362, 1999.
5. Davalos, R. V., I. L. M. Mir, and B. Rubinsky. Tissue ablation with irreversible electroporation. Ann. Biomed. Eng. 33(2):223-231, 2005.
6. Davalos, R. V., B. Rubinsky, and L. M. Mir. Theoretical analysis of the thermal effects during in vivo tissue electroporation. Bioelectrochemistry 61(1-2):99-107, 2003.
7. Deodhar, A., T. Dickfeld, G. W. Single, W. C. Hamilton, R. H. Thornton, C. T. Sofocleous, M. Maybody, M. Gó nen, B. Rubinsky, and S. B. Solomon. Irreversible electroporation near the heart: ventricular arrhythmias can be prevented with ECG synchronization. AJR Am. J. Roentgenol. 196(3):W330-W335, 2011.
8. Deodhar, A., S. Monette, G. W. Single, Jr., W. C. Hamilton, Jr., R. Thornton, M. Maybody, J. A. Coleman, and S. B. Solomon. Renal tissue ablation with irreversible electroporation: preliminary results in a porcine model. Urology 77(3):754-760, 2011.
9. Devireddy, R. V. Statistical thermodynamics of biomembranes. Cryobiology 60(1):80-90, 2010.
10. Edd, J. F., L. Horowitz, R. V. Davalos, L. M. Mir, and B. Rubinsky. In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans. Biomed. Eng. 53(7):1409-1415, 2006.
11. Ellis, T. L., P. A. Garcia, J. H. Rossmeisl, N. Henao-Guerrero, J. Robertson, and R. V. Davalos. Nonthermal irreversible electroporation for intracranial surgical applications. J. Neurosurg. 114(3):681-688, 2011.
12. Fedorov, V. V., V. P. Nikolski, and I. R. Efimov. Effect of electroporation on cardiac electrophysiology. Methods Mol. Biol. 423:433-448, 2008.
13. Frandsen, S. K., H. Gissel, P. Hojman, T. Tramm, J. Eriksen, and J. Gehl. Direct therapeutic applications of calcium electroporation to effectively induce tumor necrosis. Cancer Res. 72(6):1336-1341, 2012.
14. Garcia, P. A., J. H. Rossmeisl, Jr., and R. V. Davalos. Electrical conductivity changes during irreversible electroporation treatment of brain cancer. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2011:739-742, 2011.
15. Garcia, P. A., J. H. Rossmeisl, Jr., R. E. Neal, 2nd, T. L. Ellis, J. D. Olson, N. Henao-Guerrero, J. Robertson, and R. V. Davalos. Intracranial nonthermal irreversible electroporation: in vivo analysis. J. Membr. Biol. 236(1):127-136, 2010.
16. Gehl, J. G. Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol. Scand. 177(4):437-447, 2003.
17. Goel, R., K. Anderson, J. Slaton, F. Schmidlin, G. Vercellotti, J. Belcher, and J.C. Bischof. Adjuvant approaches to enhance cryosurgery. J. Biomech. Eng. 131(7):074003, 2009.
18. Goel, R., D. Swanlund, J. Coad, G. F. Paciotti, and J. C. Bischof. TNF-a-based accentuation in cryoinjury-dose, delivery, and response. Mol. Cancer Ther. 6(7):2039-2047, 2007.
19. Golberg, A., and M. L. Yarmush. Nonthermal irreversible electroporation: fundamentals, applications, and challenges. IEEE Trans. Biomed. Eng. 60(3):707-714, 2013.
20. Gothelf, A., L. M. Mir, and J. Gehl. Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat. Rev. 29(5):371-387, 2003.
21. Guo, Y., Y. Zhang, R. Klein, G. M. Nijm, A. V. Sahakian, R. A. Omary, G.-Y. Yang, and A. C. Larson. Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma. Cancer Res. 70(4):1555-1563, 2010.
22. Karatekin, E., O. Sandre, H. Guitouni, N. Borghi, P.-H. Puech, and F. Brochard-Wyart. Cascades of transient pores in giant vesicles: line tension and transport. Biophys. J. 84(3):1734-1749, 2003.
23. Lavee, J., G. Onik, P. Mikus, and B. Rubinsky. A novel nonthermal energy source for surgical epicardial atrial ablation: irreversible electroporation. Heart Surg. Forum 10:162-167, 2007.
24. Lee, R. C. Physical mechanisms of tissue injury in electrical trauma. IEEE Trans. Educ. 34(3):223-230, 1991.
25. Long, G., G. Bakos, P. K. Shires, L. Gritter, J. W. Crissman, J. L. Harris, and J. W. Clymer. Histological and finite element analysis of cell death due to irreversible electroporation. TCRT Express, 2013.
26. Lu, D. S., S. S. Raman, D. J. Vodopich, M. Wang, J. Sayre, and C. Lassman. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs assessment of the 'heat sink' effect. Am. J. Roentgenol. 178(1):47-51, 2002.
27. Miller, L., J. Leor, and B. Rubinsky. Cancer cells ablation with irreversible electroporation. Technol. Cancer Res. Treat. 4(6):699-705, 2005.
28. Mir, L. M. Therapeutic perspectives of in vivo cell electropermeabilization. Bioelectrochemistry 53(1):1-10, 2001.
29. Moldovan, D., D. Pinisetty, and R. V. Devireddy. Molecular dynamics simulation of pore growth in lipid bilayer membranes in the presence of edge-active agents. Appl. Phys. Lett. 91(20):204104-204104-3, 2007.
30. Onik, G., P. Mikus, and B. Rubinsky. Irreversible electroporation: implications for prostate ablation. Technol. Cancer Res. Treat. 6(4):295-300, 2007.
31. Pech, M., A. Janitzky, J. J. Wendler, C. Strang, S. Blaschke, O. Dudeck, J. Ricke, and U. B. Liehr. Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study. Cardiovasc. Intervent. Radiol. 34(1):132-138, 2011.
32. Powell, K. T., and J. C. Weaver. Transient aqueous pores in bilayer membranes: a statistical theory. Bioelectrochem. Bioenerg. 15(2):211-227, 1986.
33. Qin, Z., J. Jiang, G. Long, B. Lindgren, and J. C. Bischof. Irreversible electroporation: an in vivo study with dorsal skin fold chamber. Ann. Biomed. Eng. 41:619-629, 2013.
34. Rubinsky, B., G. Onik, and P. Mikus. Irreversible electroporation: a new ablation modality-clinical implications. Technol. Cancer Res. Treat. 6(1):37-48, 2007.
35. Rubinsky, J., G. Onik, P. Mikus, and B. Rubinsky. Optimal parameters for the destruction of prostate cancer using irreversible electroporation. J. Urol. 180(6):2668-2674, 2008.
36. Sersa, G., T. Jarm, T. Kotnik, A. Coer, M. Podkrajsek, M. Sentjurc, D. Miklavcic, M. Kadivec, S. Kranjc, A. Secerov, and M. Cemazar. Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br. J. Cancer 98(2):388-398, 2008.
37. Shafiee, H., P. A. Garcia, and R. V. Davalos. A preliminary study to delineate irreversible electroporation from thermal damage using the Arrhenius equation. J. Biomech. Eng. 131(7):074509, 2009.
38. Toner, M., and E. G. Cravalho. Kinetics and likelihood of membrane rupture during electroporation. Phys. Lett. A 143(8):409-412, 1990.
39. Tovar, O., and L. Tung. Electroporation and recovery of cardiac cell membrane with rectangular voltage pulses. Am. J. Physiol. Heart Circ. Physiol. 263(4):H1128-H1136, 1992.
40. Tracy, C. R., W. Kabbani, and J. A. Cadeddu. Irreversible electroporation (IRE): a novel method for renal tissue ablation. BJU Int. 107(12):1982-1987, 2011.
41. Troiano, G. C., K. J. Stebe, R. M. Raphael, and L. Tung. The effects of gramicidin on electroporation of lipid bilayers. Biophys. J. 76(6):3150-3157, 1999.
42. Troiano, G. C., L. Tung, V. Sharma, and K. J. Stebe. The reduction in electroporation voltages by the addition of a surfactant to planar lipid bilayers. Biophys. J. 75(2):880-888, 1998.
43. Tsong, T. Y. Electroporation of cell membranes. Biophys. J. 60(2):297-306, 1991.
44. Tung, L., G. C. Troiano, V. Sharma, R. M. Raphael, and K. J. Stebe. Changes in electroporation thresholds of lipid membranes by surfactants and peptides. Ann. N. Y. Acad. Sci. 888(1):249-265, 1999.
45. Weaver, J. C. Electroporation of cells and tissues. IEEE Trans. Plasma Sci. 28(1):24-33, 2000.
46. Weaver, J. C., and Y. A. Chizmadzhev. Theory of electroporation: a review. Bioelectrochem. Bioenerg. 41(2):135-160, 1996.